The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study

The safety and immunogenicity of a two-dose schedule of CoronaVac, and the immune persistence of vaccination for six months, in people living with HIV: A multicenter prospective cohort study

BackgroundPeople living with HIV (PLWH) are more vulnerable to SARS-CoV-2. However, evidence on the immunogenicity of coronavirus disease 2019 (COVID-19) vaccines in this population is insufficient. The objective of this study is to assess the immunogenicity and safety of the two-dose schedule of Si...

Full description

Bibliographic Details
Main Authors: Yuxiao Wang, Ying Qiao, Yuqi Huo, Li Wang, Shijie Liang, Maohe Yu, Xinquan Lan, Moxin Song, Xiangjun Zhang, Ying Yan, Junjie Xu
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
PLWH
Sinovac CoronaVac
adverse events
neutralizing antibody
S-IgG antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129651/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129651/full

Similar Items